News Archive

Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.

Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority.

Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.